In conclusion, several studies have demonstrated the importance of miRNAs and lncRNAs as biomarkers to predict the efficacy of conventional chemotherapy, anti-VEGF and anti-EGFR targeted therapies in CRC, as summarized in Table 1. The gene discussed is EGFR; the disease is colorectal carcinoma.